Canagliflozin versus placebo for post-bariatric surgery patients with persistent type II diabetes: A randomized controlled trial (CARAT). uri icon

Overview

publication date

  • February 9, 2017

Research

keywords

  • Bariatric Surgery
  • Canagliflozin
  • Diabetes Mellitus, Type 2

Identity

Scopus Document Identifier

  • 85013498628

Digital Object Identifier (DOI)

  • 10.1111/dom.12860

PubMed ID

  • 27995724

Additional Document Info

volume

  • 19

issue

  • 4